TY - JOUR
T1 - The role of neuropeptide y for the development of allergic airway responses
AU - Miyahara, Nobuaki
N1 - Publisher Copyright:
© 2020, Japanese Pharmacological Society. All rights reserved.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020
Y1 - 2020
N2 - Neuropeptide Y (NPY) is a neurotransmitter that is widely expressed in the brain and peripheral nervous system. Various immune cells express the receptor for NPY, Y1 receptor. NPY modulates these cells via its Y1 receptor, and involvement of NPY in the pathophysiology of bronchial asthma, has been reported. Increased plasma levels of NPY in asthmatic patients have been reported. NPY polymorphisms are associated with an increased risk for asthma in overweight subjects and young adults. We and other researchers have reported that using murine models of allergic airway responses, NPY and Y1 receptor play critical roles for the development of allergic airway inflammation and airway hyperresponsiveness. Therefore, manipulating NPY-Y1 pathway represents a novel therapeutic target to control allergic airway responses, and might be beneficial for treatment of bronchial asthma.
AB - Neuropeptide Y (NPY) is a neurotransmitter that is widely expressed in the brain and peripheral nervous system. Various immune cells express the receptor for NPY, Y1 receptor. NPY modulates these cells via its Y1 receptor, and involvement of NPY in the pathophysiology of bronchial asthma, has been reported. Increased plasma levels of NPY in asthmatic patients have been reported. NPY polymorphisms are associated with an increased risk for asthma in overweight subjects and young adults. We and other researchers have reported that using murine models of allergic airway responses, NPY and Y1 receptor play critical roles for the development of allergic airway inflammation and airway hyperresponsiveness. Therefore, manipulating NPY-Y1 pathway represents a novel therapeutic target to control allergic airway responses, and might be beneficial for treatment of bronchial asthma.
UR - http://www.scopus.com/inward/record.url?scp=85094867750&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094867750&partnerID=8YFLogxK
U2 - 10.1254/fpj.20036
DO - 10.1254/fpj.20036
M3 - Article
C2 - 33132250
AN - SCOPUS:85094867750
SN - 0015-5691
VL - 155
SP - 360
EP - 363
JO - Folia Pharmacologica Japonica
JF - Folia Pharmacologica Japonica
IS - 6
ER -